Dennis Cho
Fortuna: 8 M $ al 31/05/2026
Fortuna: 8 M $ al 31/05/2026
En la actualidad, Dennis Hohn Cho es Vicepresidente Senior, Director de Ética y Cumplimiento en Twist Bioscience Corp. En el pasado, el Sr. Cho ocupó el cargo de Consejero General Adjunto en CytomX Therapeutics, Inc. y de Vicepresidente Senior de Asuntos Comerciales y Consejero General en Image Entertainment, Inc. Se licenció y se graduó en la Universidad de California, Berkeley.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP. 0,19 % | 08/06/2026 | 119.692 ( 0,19 % ) | 8 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Consejero General | 27/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
| SEAGEN INC. | Director/Miembro de la Junta | 01/01/2021 |
| CELGENE | Director/Miembro de la Junta | 01/12/2019 |
| CYTOMX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Image Entertainment, Inc.
Image Entertainment, Inc. Movies/EntertainmentConsumer Services Distributes home entertainment programming on different formats and platforms | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Image Entertainment, Inc.
Image Entertainment, Inc. Movies/EntertainmentConsumer Services Distributes home entertainment programming on different formats and platforms | Consumer Services |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Twist Bioscience Corp.
Twist Bioscience Corp. BiotechnologyHealth Technology Manufactures, distributes and sells synthetic DNA products through online | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.